Skip to content
Disclosery

EXANE DERIVATIVES: BABA position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on BABA, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 9,429 BABA shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 9,429 shares
    Change vs previous 13F -1,082 shares

    0.62% of the 13F portfolio, value $1,071,652.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 10,511 shares
    Change vs previous 13F -4,016 shares

    0.32% of the 13F portfolio, value $1,143,511.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 14,527 shares
    Change vs previous 13F -1,794 shares

    0.42% of the 13F portfolio, value $1,725,576.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 16,321 shares
    Change vs previous 13F +4,396 shares

    0.6% of the 13F portfolio, value $2,416,204.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 11,925 shares
    Change vs previous 13F +1,103 shares

    0.59% of the 13F portfolio, value $2,498,329.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 10,822 shares
    Change vs previous 13F +5,276 shares

    0.74% of the 13F portfolio, value $2,453,523.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 5,546 shares
    Change vs previous 13F +1,590 shares

    0.39% of the 13F portfolio, value $1,290,640.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 3,956 shares
    Change vs previous 13F not available

    0.38% of the 13F portfolio, value $1,162,937.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).